Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000006

Director acquired 1,568 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anderson Kenneth Carl Director 2023-01-03 Grant or award +1,568 $6.38 $10,004 94,416 D: show line 1 in the form
Loading xslF345X03/wf-form4_167286703601250.xml…